Trevi Therapeutics, Inc. ( TRVI) - Stock Earnings
TRVI Upcoming earnings
Estimated EPS and revenue columns are available to paid members.
| Date | EPS (actual / est.) | Revenue low (est.) | Revenue (actual / est.) | Revenue high (est.) |
|---|---|---|---|---|
| Nov. 12, 2026, midnight | — / — | — | — / — | — |
TRVI Quarterly earnings
Analyst consensus estimates are available to paid members.
| Date | Earnings | Revenue |
|---|---|---|
| 2025Q4 | -8.3 million USD | — USD |
| 2026Q1 | -13.2 million USD | — USD |
| 2026Q2 | -17.8 million USD | — USD |
| 2026Q4 Est. | — | — |
| 2027Q1 Est. | — | — |
| 2027Q2 Est. | — | — |
TRVI Yearly earnings
Analyst consensus estimates are available to paid members.
| Date | Earnings | Revenue |
|---|---|---|
| 2023 | -29.1 million USD | — USD |
| 2024 | -47.9 million USD | — USD |
| 2025 | -42.8 million USD | — USD |
| 2026 Est. | — | — |
TRVI
Price: $12.09
52 week price:
Earnings Per Share: -0.35 USD
Exchange: NGM
Sector: Healthcare
Industry: Biotechnology
Country: United States
Volume: 28000
Market Capitalization: 2.0 billion